Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   ACTAVIS
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
ACTAVIS
Dec-18
ZIM LABORATORIES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38816,126-   
Low Rs6710,818-   
Sales per share (Unadj.) Rs81.83,955.8-  
Earnings per share (Unadj.) Rs5.0-1,274.2-  
Cash flow per share (Unadj.) Rs8.6416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs41.116,315.7-  
Shares outstanding (eoy) m48.73332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.83.4 81.8%   
Avg P/E ratio x45.4-10.6 -429.5%  
P/CF ratio (eoy) x26.532.3 81.9%  
Price / Book Value ratio x5.50.8 670.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m11,0964,480,758 0.2%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4930-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m3,9851,315,689 0.3%  
Other income Rs m6425,160 0.3%   
Total revenues Rs m4,0491,340,849 0.3%   
Gross profit Rs m52034,478 1.5%  
Depreciation Rs m175562,428 0.0%   
Interest Rs m5675,923 0.1%   
Profit before tax Rs m354-578,713 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m109-7,334 -1.5%   
Profit after tax Rs m244-423,784 -0.1%  
Gross profit margin %13.02.6 497.8%  
Effective tax rate %30.91.3 2,437.4%   
Net profit margin %6.1-32.2 -19.0%  
BALANCE SHEET DATA
Current assets Rs m1,909539,627 0.4%   
Current liabilities Rs m1,108477,372 0.2%   
Net working cap to sales %20.14.7 425.1%  
Current ratio x1.71.1 152.5%  
Inventory Days Days1920 99.5%  
Debtors Days Days87266 1,315.6%  
Net fixed assets Rs m1,569148,929 1.1%   
Share capital Rs m4870-   
"Free" reserves Rs m1,5160-   
Net worth Rs m2,0035,426,601 0.0%   
Long term debt Rs m2461,910,903 0.0%   
Total assets Rs m3,4798,483,012 0.0%  
Interest coverage x7.3-6.6 -110.9%   
Debt to equity ratio x0.10.4 34.9%  
Sales to assets ratio x1.10.2 738.6%   
Return on assets %8.6-4.1 -210.4%  
Return on equity %12.2-7.8 -156.2%  
Return on capital %18.2-4.8 -375.8%  
Exports to sales %81.10-   
Imports to sales %12.20-   
Net fx Rs m2,7960-   
CASH FLOW
From Operations Rs m375470,046 0.1%  
From Investments Rs m-362258,229 -0.1%  
From Financial Activity Rs m5-806,740 -0.0%  
Net Cashflow Rs m30-78,073 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ZIM LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ZIM LABORATORIES With: BDH INDUS.  SEQUENT SCIENTIFIC  SHILPA MEDICARE  AJANTA PHARMA  CAPLIN POINT  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.